Expanded Antigen-Specific Elimination Assay to Measure Human CD8⁺ T Cell Cytolytic Potential

Area of Science:

• Immunology
• Cellular Biology
• Virology

Background:

• Durable cellular immunity relies on memory CD8+ T cells' recall response to antigens.
• Conventional assays struggle to measure the secondary cytotoxic potential of T cells without recent in vivo antigen exposure.
• Assessing T cell memory function is crucial for understanding pathogen clearance and vaccine efficacy.

Purpose of the Study:

• To introduce the Expanded Antigen-specific Elimination Assay (EASEA), a novel flow cytometry-based method.
• To quantify the capacity of human CD8+ T cells to proliferate and generate cytotoxic effector cells upon antigen re-exposure in vitro.
• To provide a safer and more adaptable alternative to existing assays for studying T cell-mediated cytotoxicity.

Main Methods:

• Development of EASEA, a flow cytometric assay for measuring CD8+ T cell expansion and elimination capacity.
• Utilizing autologous antigen-pulsed target cells to assess selective elimination across varying effector-to-target ratios.
• Comparing EASEA to conventional assays, highlighting its avoidance of radioactive labeling and viral infection.

Main Results:

• EASEA successfully measures the in vitro expansion and secondary effector cell generation of antigen-specific CD8+ T cells.
• The assay demonstrates the capacity of these cells to selectively eliminate target cells.
• EASEA offers a versatile platform for studying responses to individual or pooled antigens.

Conclusions:

• EASEA is a valuable tool for assessing functional memory CD8+ T cell responses.
• The assay provides a safer and more adaptable alternative for immunological research.
• Understanding T cell recall responses is critical for developing effective immunotherapies and vaccines.